" /> COVID-19 Vaccine Ad26.COV2.S - CISMeF





Preferred Label : COVID-19 Vaccine Ad26.COV2.S;

NCIt synonyms : Johnson and Johnson COVID-19 Vaccine; Ad26-encoding SARS-CoV-2 Spike Protein Vaccine; Ad26COVS1; Ad26.COV2.S;

NCIt related terms : Johnson & Johnson COVID-19 Vaccine; Ad26.COV2.S (Johnson & Johnson/Janssen);

NCIt definition : A coronavirus vaccine composed of a genetically engineered, replication-incompetent, adenovirus serotype 26 (Ad26) vector expressing the stabilized pre-fusion spike (S) protein of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), with potential immunomodulating and anti-COVID-19 activities. Upon intramuscular administration of the COVID-19 vaccine Ad26.COV2.S, the Ad26 infects human cells, which produces SARS-CoV-2 S protein. The released S protein activates the immune system to induce a humoral and cell-mediated immune response against SARS-CoV-2. This may prevent SARS-CoV-2 infection and inhibit viral replication. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.;

UNII : JT2NS6183B;

Molecule name : JNJ 78436735; JNJ-78436735;

NCI Metathesaurus CUI : CL1651091;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
21/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.